USO 19225

Trial Information

A Phase Ib, Open-Label, Multicenter Study Evaluating the Safety and Efficacy Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castrate Resistant Prostate Cancer

Contact us regarding Clinical Trials at
or call us at 877-664-7724

Disease Types

Prostate Cancer


Quality Care Close to Home

View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology